NZ596015A - Method and composition for the treatment of pain and/or inflammation - Google Patents
Method and composition for the treatment of pain and/or inflammationInfo
- Publication number
- NZ596015A NZ596015A NZ596015A NZ59601511A NZ596015A NZ 596015 A NZ596015 A NZ 596015A NZ 596015 A NZ596015 A NZ 596015A NZ 59601511 A NZ59601511 A NZ 59601511A NZ 596015 A NZ596015 A NZ 596015A
- Authority
- NZ
- New Zealand
- Prior art keywords
- pain
- inflammation
- treatment
- composition
- vitamin
- Prior art date
Links
- 208000002193 Pain Diseases 0.000 title abstract 3
- 206010061218 Inflammation Diseases 0.000 title abstract 2
- 230000004054 inflammatory process Effects 0.000 title abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 4
- 229930003316 Vitamin D Natural products 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 235000019166 vitamin D Nutrition 0.000 abstract 2
- 239000011710 vitamin D Substances 0.000 abstract 2
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 2
- 235000005282 vitamin D3 Nutrition 0.000 abstract 2
- 239000011647 vitamin D3 Substances 0.000 abstract 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 abstract 2
- 229940046008 vitamin d Drugs 0.000 abstract 2
- 229940021056 vitamin d3 Drugs 0.000 abstract 2
- 208000007920 Neurogenic Inflammation Diseases 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ596015A NZ596015A (en) | 2011-10-26 | 2011-10-26 | Method and composition for the treatment of pain and/or inflammation |
PCT/NZ2012/000195 WO2013062424A1 (en) | 2011-10-26 | 2012-10-25 | Method and composition for the treatment of pain and/or inflammation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ596015A NZ596015A (en) | 2011-10-26 | 2011-10-26 | Method and composition for the treatment of pain and/or inflammation |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ596015A true NZ596015A (en) | 2014-04-30 |
Family
ID=48168134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ596015A NZ596015A (en) | 2011-10-26 | 2011-10-26 | Method and composition for the treatment of pain and/or inflammation |
Country Status (2)
Country | Link |
---|---|
NZ (1) | NZ596015A (en) |
WO (1) | WO2013062424A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN2014CH01872A (en) | 2014-04-09 | 2015-05-08 | Nanoceutica Lab Pvt Ltd | |
AU2016102480A4 (en) * | 2015-05-12 | 2021-12-23 | Brinnson IP Limited | New treatment methods utilising lactose compositions |
CN104997806A (en) * | 2015-07-23 | 2015-10-28 | 四川科伦药业股份有限公司 | Compound sodium acetate ringer injection and preparation method and quality control method thereof |
CN113440440B (en) * | 2021-07-26 | 2022-06-07 | 宝萃生物科技有限公司 | Skin barrier repair composition and preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2245511T3 (en) * | 1998-03-04 | 2006-01-01 | Teijin Limited | VITAMIN LOANS D3 ACTIVE IN THE FORM OF EMULSION. |
WO2003053336A2 (en) * | 2001-12-19 | 2003-07-03 | The Quigley Corporation | Methods for the treatment of peripheral neural and vascular ailments |
US20060275237A1 (en) * | 2005-05-09 | 2006-12-07 | Bissett Donald L | Skin care compositions containing idebenone |
-
2011
- 2011-10-26 NZ NZ596015A patent/NZ596015A/en unknown
-
2012
- 2012-10-25 WO PCT/NZ2012/000195 patent/WO2013062424A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2013062424A1 (en) | 2013-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011007183A3 (en) | Skin care composition for the treatment of acne vulgaris | |
WO2015095819A3 (en) | Cancer treatment using combinations of erk and raf inhibitors | |
MX2011008912A (en) | Topical foam composition. | |
MX359626B (en) | Compositions comprising selenium and use of same for the treatment and prevention of disease or conditions associated with mitochondrial dysfunction. | |
IN2014DN05786A (en) | ||
WO2012145651A3 (en) | Compounds for the treatment of neuropsychiatric disorders | |
WO2013024282A3 (en) | Inhibitor or down- regulator of the expression of one or both of tbk1 ikk-epsilon for use in the treatment of pi3kinase dependent cancer | |
MX363465B (en) | Treatment of submental fat. | |
MX2014008021A (en) | Phenyl carbamate compounds for use in alleviating or treating pain and neuropathic pain. | |
WO2012050831A3 (en) | Combination treatment for dermatological conditions | |
WO2009129531A3 (en) | Bupivacaine formulation in a polyorthoester carrier | |
WO2013060771A3 (en) | Composition containing an extract of a sequential or simultaneous fermentation | |
MX365366B (en) | Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne. | |
NZ596015A (en) | Method and composition for the treatment of pain and/or inflammation | |
EA201401031A1 (en) | A HALF-LEVELED COMPOSITION FOR LOCAL APPLICATION THAT CONTAINS Pyrphenidone and Modified Diallyldisulfide Oxide (M-DDO) to Remove or Prevent Ugrey | |
WO2015095838A3 (en) | Cancer treatments using combinations of mek type i and erk inhibitors | |
MX2016008102A (en) | Compositions and methods for treating fatty tissue buildup. | |
WO2009129527A3 (en) | Baclofen formulation in a polyorthoester carrier | |
WO2011001111A3 (en) | Use of jasmonic acid to treat oily skin | |
MX2015015200A (en) | "inhibitors of nicotinamide phosphoribosyltransferase, compositions, products and uses thereof". | |
GB2525517A (en) | Topical preparation for pain relief | |
MX353580B (en) | Monounsaturated fatty acid for preventing and/or treating skin complexion imperfections. | |
WO2011085013A3 (en) | Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same | |
WO2014030117A3 (en) | Cosmetic use of the essential oil of laserpitium siler l. against the signs of aging of the skin and as a skin antioxidant | |
WO2015017383A3 (en) | Compositions and methods of the treatment of fatty acid metabolism disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: PHARMACEUTICAL COMPOUNDING NZ LIMITED, NZ Free format text: OLD OWNER(S): PHARMACEUTICAL COMPOUNDING NZ LIMITED; PHARMACEUTICAL COMPOUNDING NZ LIMITED; JOHN LYFTOGT; MICHAEL CUSHMAN Owner name: MICHAEL CUSHMAN, NZ Free format text: OLD OWNER(S): PHARMACEUTICAL COMPOUNDING NZ LIMITED; PHARMACEUTICAL COMPOUNDING NZ LIMITED; JOHN LYFTOGT; MICHAEL CUSHMAN |
|
ASS | Change of ownership |
Owner name: PHARMACEUTICAL COMPOUNDING NZ LIMITED, NZ Free format text: OLD OWNER(S): PHARMACEUTICAL COMPOUNDING NZ LIMITED; MICHAEL CUSHMAN |
|
ASS | Change of ownership |
Owner name: ANZAMED INTERNATIONAL LIMITED, NZ Free format text: OLD OWNER(S): PHARMACEUTICAL COMPOUNDING NZ LIMITED |
|
PSEA | Patent sealed | ||
ASS | Change of ownership |
Owner name: JAN ANNE LYFTOGT, NZ Effective date: 20160519 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2017 BY CREATEIP Effective date: 20160815 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2018 BY CREATEIP Effective date: 20170801 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2019 BY CREATEIP Effective date: 20180727 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2020 BY CREATEIP Effective date: 20190801 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2021 BY CREATEIP Effective date: 20200728 |
|
ASS | Change of ownership |
Owner name: HOROPITO LIMITED, GB Effective date: 20201214 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2022 BY CREATEIP Effective date: 20210823 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2023 BY CREATEIP Effective date: 20220928 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 25 OCT 2024 BY CREATEIP Effective date: 20231019 |